179 related articles for article (PubMed ID: 20435175)
21. Ezetimibe-Statin Combination to Reduce Cardiovascular Events: The Evidence Base.
Jialal I; Abate N
Metab Syndr Relat Disord; 2015 Oct; 13(8):327-8. PubMed ID: 26177147
[No Abstract] [Full Text] [Related]
22. Effect of ezetimibe coadministration with simvastatin in a Middle Eastern population: a prospective, multicentre, randomized, double-blind, placebo-controlled trial.
Zubaid M; Shakir DK; Bazargani N; Binbrek A; Gopal R; Al-Tamimi O; Bakir S
J Cardiovasc Med (Hagerstown); 2008 Jul; 9(7):688-93. PubMed ID: 18545068
[TBL] [Abstract][Full Text] [Related]
23. LDL-Cholesterol is the King.
Goumas GS
Angiology; 2009; 60(3):387-8. PubMed ID: 19497926
[No Abstract] [Full Text] [Related]
24. Ezetimibe plus moderate-dose simvastatin after acute coronary syndrome: what are we IMPROVEing on?
DiNicolantonio JJ; Chatterjee S; Lavie CJ; Bangalore S; O'Keefe JH
Am J Med; 2015 Aug; 128(8):914.e1-4. PubMed ID: 25731133
[TBL] [Abstract][Full Text] [Related]
25. Low-density lipoprotein cholesterol reduction and goal achievement with ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes, metabolic syndrome, or neither disease, stratified by National Cholesterol Education Program risk category.
Polis AB; Abate N; Catapano AL; Ballantyne CM; Davidson MH; Smugar SS; Tershakovec AM
Metab Syndr Relat Disord; 2009 Dec; 7(6):601-10. PubMed ID: 19929597
[TBL] [Abstract][Full Text] [Related]
26. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
Catapano AL; Davidson MH; Ballantyne CM; Brady WE; Gazzara RA; Tomassini JE; Tershakovec AM
Curr Med Res Opin; 2006 Oct; 22(10):2041-53. PubMed ID: 17022864
[TBL] [Abstract][Full Text] [Related]
27. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
Daskalopoulou SS; Mikhailidis DP
Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035
[TBL] [Abstract][Full Text] [Related]
28. ["The lower LDL cholesterol levels, the better" still valid. Negative/neutral conclusions of three studies on statins do not change the clinical practice].
Olsson AG; Nilsson PM
Lakartidningen; 2009 Mar 18-24; 106(12):854-7. PubMed ID: 19452786
[No Abstract] [Full Text] [Related]
29. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
[TBL] [Abstract][Full Text] [Related]
30. Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study.
Farnier M; Averna M; Missault L; Vaverkova H; Viigimaa M; Massaad R; Vandormael K; Johnson-Levonas AO; Brudi P
Int J Clin Pract; 2009 Apr; 63(4):547-59. PubMed ID: 19222610
[TBL] [Abstract][Full Text] [Related]
31. [Effects of aggressive therapy with simvastatin in patients with acute coronary syndrome and initially normal level of LDLP cholesterol on cardiovascular outcomes (LAOKOON). Pilot randomized trial].
Arutiunov GP; Kartseva TP; Voevodina NIu; Daĭter II; Malanichev RV; Marfunina AA; Nakhaev VI; Rozanov AV; Rylova AK; Stepanova LV
Ter Arkh; 2005; 77(9):53-60. PubMed ID: 16281491
[TBL] [Abstract][Full Text] [Related]
32. [Coronary heart disease patient reaches LDL level of 100 mg/dl with atorvastatin: how do you continue treatment next year?].
Weizel A; Sawicki PT
MMW Fortschr Med; 2004 Dec; 146(51-52):14, 16. PubMed ID: 15675236
[No Abstract] [Full Text] [Related]
33. Ezetimibe/simvastatin.
Montecucco F; Quercioli A; Mach F
Expert Opin Drug Saf; 2009 Nov; 8(6):715-25. PubMed ID: 19968571
[TBL] [Abstract][Full Text] [Related]
34. [Coronary disease prevention: only the inhibition of inflammation is important. Why lower lipids, too?].
Sudhop T; von Bergmann K
MMW Fortschr Med; 2003 May; 145(21):19. PubMed ID: 12845862
[No Abstract] [Full Text] [Related]
35. [How far the rates of cholesterol have to be lowered in primary prevention?].
Rodondi N
Rev Med Suisse; 2010 Mar; 6(239):483-4. PubMed ID: 20373693
[No Abstract] [Full Text] [Related]
36. Ezetimibe/simvastatin single tablet versus rosuvastatin in patients with hypercholesterolemia.
Daskalopoulou SS; Mikhailidis DP
Curr Med Res Opin; 2006 Oct; 22(10):2037-9. PubMed ID: 17022863
[TBL] [Abstract][Full Text] [Related]
37. No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance.
Malmström RE; Settergren M; Böhm F; Pernow J; Hjemdahl P
Thromb Haemost; 2009 Jan; 101(1):157-64. PubMed ID: 19132203
[TBL] [Abstract][Full Text] [Related]
38. Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: an analysis of 65,396 hospitalizations from 344 hospitals participating in Get With The Guidelines (GWTG).
Javed U; Deedwania PC; Bhatt DL; Cannon CP; Dai D; Hernandez AF; Peterson ED; Fonarow GC
Am Heart J; 2010 Dec; 160(6):1130-6, 1136.e1-3. PubMed ID: 21146668
[TBL] [Abstract][Full Text] [Related]
39. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
[No Abstract] [Full Text] [Related]
40. Switching statin therapy using a pharmacist-managed therapeutic conversion program versus usual care conversion among indigent patients.
Miller AE; Hansen LB; Saseen JJ
Pharmacotherapy; 2008 May; 28(5):553-61. PubMed ID: 18447653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
